iifl-logo

PGIM India Healthcare Fund Direct G

PGIM India Healthcare Fund Direct G

Fund Name

PGIM India Mutual Fund

Scheme Name

PGIM India Healthcare Fund Direct G

AMC

PGIM India Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

19-Nov-2024

Fund Manager

Anandha Padmanabhan Anjen

Net Assets (Rs. cr)

107.51

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

PGIM India Healthcare Fund Direct G - Nav Details

Nav Date

:  05-Jun-2025

NAV [Rs.]

:  9.74

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

For Exits within 90 days from date of allotment of units: 0.50% For Exits beyond 90 days from date of allotment of units: NIL

PGIM India Healthcare Fund Direct G- NAV Chart

PGIM India Healthcare Fund Direct G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
1.03
1.24
9.19
-
-
-
-
-2.6
Category Avg
0.64
1.74
8.92
-3.8
19.89
24.84
22.23
17.69
Category Best
1.32
5.25
15.13
-0.14
30.95
29.5
26.01
36.02
Category Worst
-0.06
-0.33
4.57
-8.85
11.81
20.12
16.87
-4.96

PGIM India Healthcare Fund Direct G- Latest Dividends

No Records Found

PGIM India Healthcare Fund Direct G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology13.067664814.04
EquityDivi's Lab.Pharmaceuticals & Biotechnology7.75136968.33
EquityMax HealthcareHealthcare Services6.94679217.45
EquityDr Reddy's LabsPharmaceuticals & Biotechnology6.04548916.49
EquityMankind PharmaPharmaceuticals & Biotechnology4.83210755.19
EquityAster DM Health.Healthcare Services4.781018495.14
EquityTorrent Pharma.Pharmaceuticals & Biotechnology3.90126104.18
EquityKrishna Institu.Healthcare Services3.58585773.84
EquityAjanta PharmaPharmaceuticals & Biotechnology3.33132403.58
EquityAbbott IndiaPharmaceuticals & Biotechnology3.3111883.56
EquityJ B Chemicals &Pharmaceuticals & Biotechnology3.15210143.38
EquityGlobal HealthHealthcare Services2.95264713.16
EquityICICI LombardInsurance2.86163883.07
EquityCiplaPharmaceuticals & Biotechnology2.84197003.05
EquityPB Fintech.Financial Technology (Fintech)2.61172622.80
EquityDr Lal PathlabsHealthcare Services2.4394452.61
EquityJupiter Life LinHealthcare Services2.27166302.44
EquityNavin Fluo.Intl.Chemicals & Petrochemicals2.1851912.34
EquityIpca Labs.Pharmaceuticals & Biotechnology2.10160842.25
EquitySyngene Intl.Healthcare Services2.06350052.21
EquityRainbow Child.Healthcare Services1.93150352.07
EquitySagility IndiaIT - Services1.914999082.05
EquityNeuland Labs.Pharmaceuticals & Biotechnology1.8916942.03
EquitySanofi ConsumerPharmaceuticals & Biotechnology1.8139361.94
EquitySanofi IndiaPharmaceuticals & Biotechnology1.6028971.72
EquityZydus Lifesci.Pharmaceuticals & Biotechnology0.97117661.04
EquitySai LifePharmaceuticals & Biotechnology0.93145741.01
EquityOrchid PharmaPharmaceuticals & Biotechnology0.7296410.77
EquityAkums DrugsPharmaceuticals & Biotechnology0.2960410.31
Cash & Cash Equivalent
Reverse RepoC C I-/-4.5404.88
Net CA & OthersNet CA & Others-/-0.4300.42

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
PGIM India Mutual Fund
Incorporation Date:
24-Sep-2008
Total Assets Managed (Cr.):
24,164.95
Trustee/s:
Rakesh Sood, PGIM India Trustees Priva, Mr. Vijay Agarwal, Mr. Sujal Shah, Mr. John Praveen, Mr. Ashwini Kakkar
Chairman:
NA
CEO / MD:
Ajit Menon, Mr. Ajit Menon
CIO:
NA
President:
NA
Director/s:
Mr.Muralidharan Rajamani, Glenwyn Peter Baptist, Kapil Wadhawan, Mr.David Wan Chang, Mr.Indrasena Yala Reddy, Dr. V. R. Narasimham
Compliance Officer/s:
Mr. Sandeep Kamath, Mr. Sumesh Kumar
Investor Service Officer/s:
Murali Ramasubramanian
Fund Manager/s:
Anandha Padmanabhan Anjen
Auditors:
Price Waterhouse Chartere

OTHER INFORMATION

Registered Office:
4th Floor, C Wing, Laxmi Towers, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051
Contact Nos:
022-61593000
Fax:
022-61593100
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.